Instil Bio (formerly Immetacyte, Cellular Therapeutics) is an immuno-oncology company that specializes in cell therapies. Its technology platform is based on the use of tumor-infiltrating lymphocytes (TILs), T-cells isolated from the patient’s tumor that can recognize and destroy cancer. The company leverages TIL technology to treat metastatic melanoma patients.
|HQ||Dallas, TX, US||Map|
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (29-Sept-2021)
Closing stock price (29-Sept-2021)
|Company Name||Date||Deal Size|
|Immetacyte Ltd.||March 31, 2020||$800 k|
|Complex Therapeutics, LLC|
|Instil Bio U.K.|
Instil Bio has 163 Twitter Followers. The number of followers has increased 8.7% month over month and increased 24.8% quarter over quarter
When was Instil Bio founded?
Instil Bio was founded in 2008.
Who are Instil Bio key executives?
Instil Bio's key executives are Bronson Crouch, Vijay Chiruvolu and Zachary Roberts.
How many employees does Instil Bio have?
Instil Bio has 150 employees.
What is Instil Bio revenue?
Latest Instil Bio annual revenue is $138 k.
What is Instil Bio revenue per employee?
Latest Instil Bio revenue per employee is $920.
Who are Instil Bio competitors?
Competitors of Instil Bio include Achilles Therapeutics, Serotiny and Expression Therapeutics.
Where is Instil Bio headquarters?
Instil Bio headquarters is located at 3963 Maple Ave #350, Dallas.
Where are Instil Bio offices?
Instil Bio has an office in Dallas.
How many offices does Instil Bio have?
Instil Bio has 2 offices.
Receive alerts for 300+ data fields across thousands of companies